Beckman Coulter Diagnostics' New Test Provides Fast Infection Differentiation in 20 Minutes Beckman Coulter Diagnostics has launched a groundbreaking assay for rapid differentiation between bacterial and viral infections, providing results in about 20 minutes.

Beckman Coulter Diagnostics' New Test Provides Fast Infection Differentiation in 20 Minutes #United_States #Brea #Beckman_Coulter #MeMed_BV #Infection_Testing

Simplicis Becomes Official Launch Partner for Beckman Coulter Life Sciences Echo Ready Initiative Simplicis has announced its role as the launch partner for Beckman Coulter's Echo Ready Digital Solutions Program, introducing the innovative Ledger™ platform.

Simplicis Becomes Official Launch Partner for Beckman Coulter Life Sciences Echo Ready Initiative #United_States #Indianapolis #Beckman_Coulter #Simplicis #Echo_Ready

Beckman Coulter Introduces the Revolutionary DxC 500i Clinical Analyzer for Efficient Diagnostics Beckman Coulter's new DxC 500i Clinical Analyzer achieves FDA clearance, offering flexibility and reliability for modern diagnostic labs, enhancing patient care.

Beckman Coulter Introduces the Revolutionary DxC 500i Clinical Analyzer for Efficient Diagnostics #United_States #Brea #Beckman_Coulter #DxC_500i #Clinical_Analyzer

Beckman Coulter Achieves FDA Breakthrough Device Status for Alzheimer's Test Beckman Coulter Diagnostics has received FDA Breakthrough Device Designation for their blood test that aids in the detection of Alzheimer's disease. This advancement promises to improve diagnosis and patient outcomes.

Beckman Coulter Achieves FDA Breakthrough Device Status for Alzheimer's Test #United_States #FDA_Approval #Alzheimer's_Disease #Brea #Beckman_Coulter

Revolutionizing Neurodegenerative Disease Research with New Immunoassays from Beckman Coulter Beckman Coulter Diagnostics has launched innovative blood-based immunoassays aimed at advancing neurodegenerative disease research, enhancing biomarker testing and patient care.

Revolutionizing Neurodegenerative Disease Research with New Immunoassays from Beckman Coulter #United_States #Neurodegenerative #Brea #Research_Use_Only #Beckman_Coulter